본문 바로가기
KERD
논문KCI 등재

Psychobiotic Therapy: Method to Reinforce the Immune System

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Psychobiotics are probiotic microorganisms that beneficially affect the central nervous system functions mediated by the gut-brain axis, improving the host’s immune system. Psychobiotic microorganisms can regulate brain pathways and serotonin production (mood controller). The main microbial genera with psychobiotic characteristics are Lactobacillus, Lactococcus and Bifidobacterium. The daily consumption of psychobiotics is called “Psychobiotic Therapy”. Psychobiotic therapy has proven antidepressant/anxiolytic properties. Psychobiotic therapy can be used to boost the host’s immune balance against pathogens, for example: virus, bacteria and fungus. Thus, psychobiotic therapy can be a promising strategy to improve and/or maintain the quality of life of people who are healthy or who suffer from anxiety/stress disorders, intestinal dysbiosis and even immunosuppressed people. This is such a hot theme it can surely only be a matter of time for psychobiotic therapy offers an “alternative treatment”, but scientific, for people diagnosed with a variety of mental/immunological disorders. Instead of targeting the mind (brain), we could go for the gut. “This new way of looking at mental health linked to gut health is literally looking at health upside down”.

Abstract

Psychobiotics are probiotic microorganisms that beneficially affect the central nervous system functions mediated by the gut-brain axis, improving the host’s immune system. Psychobiotic microorganisms can regulate brain pathways and serotonin production (mood controller). The main microbial genera with psychobiotic characteristics are Lactobacillus, Lactococcus and Bifidobacterium. The daily consumption of psychobiotics is called “Psychobiotic Therapy”. Psychobiotic therapy has proven antidepressant/anxiolytic properties. Psychobiotic therapy can be used to boost the host’s immune balance against pathogens, for example: virus, bacteria and fungus. Thus, psychobiotic therapy can be a promising strategy to improve and/or maintain the quality of life of people who are healthy or who suffer from anxiety/stress disorders, intestinal dysbiosis and even immunosuppressed people. This is such a hot theme it can surely only be a matter of time for psychobiotic therapy offers an “alternative treatment”, but scientific, for people diagnosed with a variety of mental/immunological disorders. Instead of targeting the mind (brain), we could go for the gut. “This new way of looking at mental health linked to gut health is literally looking at health upside down”.

참고문헌 (60)

  1. Eberl G, "Immunity by equilibrium", Nat Rev Immunol, 16, pp.524~532 (2016)
  2. Dinan TG, "Psychobiotics : a novel class of psychotropic", Biol Psychiatry, 74, pp.720~726 (2013)
  3. Magalhães-Guedes KT, "The dialogue between the intestine-brain axis : what is the role of probiotics?", Asian Food Sci J, 14, pp.23~27 (2020)
  4. Ross SM, "Microbiota in neuropsychiatry, part 3 : psychobiotics as modulators of mood disorders", Holist Nurs Pract, 31, pp.270~273 (2017)
  5. Petra AI, "Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation", Clin Ther, 37, pp.984~995 (2015)
  6. Wei X, "Abnormal gut microbiota metabolism specific for liver cirrhosis", Front Microbiol, 9, pp.3051~ (2018)
  7. O’Mahony SM, "Serotonin, tryptophan metabolism and the brain-gut-microbiome axis", Behav Brain Res, 277, pp.32~48 (2015)
  8. Roshchina VV, "New trends and perspectives in the evolution of neurotransmitters in microbial, plant, and animal cells", Adv Exp Med Biol, 874, pp.25~77 (2016)
  9. Sarkar A, "Psychobiotics and the manipulation of bacteria-gut-brain signals", Trends Neurosci, 39, pp.763~781 (2016)
  10. Tian P, "Towards a psychobiotic therapy for depression : Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice", Neurobiol Stress, 12, pp.100216~ (2020)
  11. Martinowich K, "Interaction between BDNF and serotonin : role in mood disorders", Neuropsychopharmacology, 33, pp.73~83 (2008)
  12. Cheng LH, "Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders", J Food Drug Anal, 27, pp.632~648 (2019)
  13. Sudo N, "Postnatal microbial colonization programs the hypothalamicpituitary-adrenal system for stress response in mice", J Physiol, 558(Pt 1), pp.263~275 (2004)
  14. Silverman MN, "Glucocorticoid regulation of inflammation and its functional correlates : from HPA axis to glucocorticoid receptor dysfunction", Ann N Y Acad Sci, 1261, pp.55~63 (2012)
  15. Jane Pei-Chen Chang, "Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents", Clinical Psychopharmacology and Neuroscience, 18(4), pp.469~483 (2020), 대한정신약물학회[DOI]
  16. Fidélix M, "Microbiota modulation and effects on metabolic biomarkers by orange juice : a controlled clinical trial", Food Funct, 11, pp.1599~1610 (2020)
  17. Gibson GR, "Dietary modulation of the human colonic microbiota : updating the concept of prebiotics", Nutr Res Rev, 17, pp.259~275 (2004)
  18. Betiku OC, "Differences in amino acid catabolism by gut microbes with", without prebiotics inclusion in GDDY-based diet affect feed utilization in rainbow trout, 2018, pp.490, 108~119
  19. Sun MF, "Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease", Ageing Res Rev, 45, pp.53~61 (2018)
  20. Vaiserman AM, "Gut microbiota : a player in aging and a target for anti-aging intervention", Ageing Res Rev, 35, pp.36~45 (2017)
  21. Vanuytsel T, "Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism", Gut, 63, pp.1293~1299 (2014)
  22. Huo R, "Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis", Front Cell Infect Microbiol, 7, pp.489~ (2017)
  23. Bercik P, "Microbes and the gut-brain axis", Neurogastroenterol Motil, 24, pp.405~413 (2012)
  24. Wang Y, "Probiotic supplements : hope or hype?", Front Microbiol, 11, pp.160~ (2020)
  25. Mousavi SN, "Effect of daily probiotic yogurt consumption on inflammation : a systematic review and meta-analysis of randomized Controlled Clinical trials", Obes Med, 18, pp.100221~ (2020)
  26. Santos MS, "Probiotic yogurt with Brazilian red propolis : physicochemical and bioactive properties, stability, and shelf life", J Food Sci, 84, pp.3429~3436 (2019)
  27. Magalhães KT, "Comparative study of the biochemical changes and volatile compound formations during the production of novel whey-based kefir beverages and traditional milk kefir", Food Chem, 126, pp.249~253 (2011)
  28. Puerari C, "New cocoa pulp-based kefir beverages : Microbiological, chemical composition and sensory analysis", Food Res Int, 48, pp.634~640 (2012)
  29. Andrade AB, "Kombucha-based cocoa honey beverage", World Appl Sci J, 38, pp.58~64 (2020)
  30. Magalhães-Guedes KT, "Kombucha and kefir are foods of the 21st century : a opinion", J Biotech Biores, 2, pp.01~02 (2019)
  31. Cross ML, "Microbes versus microbes : immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens", FEMS Immunol Med Microbiol, 34, pp.245~253 (2002)
  32. Maassen CB, "Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains", Vaccine, 18, pp.2613~2623 (2000)
  33. Shu Q, "Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001(DR20)against Escherichia coli O157 : H7 infection in mice", FEMS Immunol Med Microbiol, 34, pp.59~64 (2002)
  34. Perdigón G, "Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria", J Dairy Sci, 82, pp.1108~1114 (1999)
  35. Shu Q, "Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model", J Pediatr Gastroenterol Nutr, 33, pp.171~177 (2001)
  36. Akkasheh G, "Clinical and metabolic response to probiotic administration in patients with major depressive disorder : a randomized, double-blind, placebo-controlled trial", Nutrition, 32, pp.315~320 (2016)
  37. De Lorenzo A, "Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial", J Transl Med, 15, pp.135~ (2017)
  38. Ghorbani Z, "The effect of synbiotic as an adjuvant therapy to fluoxetine in moderate depression : a randomized multicenter trial", Arch Neurosci, 5, pp.e60507~ (2018)
  39. Kazemi A, "Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder : a randomized clinical trial", Clin Nutr, 38, pp.522~528 (2019)
  40. 김현숙, "Dietary Supplementation of Probiotic Bacillus polyfermenticus, Bispan Strain, Modulates Natural Killer Cell and T Cell Subset Populations and Immunoglobulin G Levels in Human Subjects", Journal of Medicinal Food, 9(3), pp.321~327 (2006), 한국식품영양과학회
  41. Kouchaki E, "Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis : a randomized, double-blind, placebo-controlled trial", Clin Nutr, 36, pp.1245~1249 (2017)
  42. Lee YJ, "Supplementation with the probiotic strain Weissella cibaria JW15 enhances natural killer cell activity in nondiabetic subjects", J Funct Foods, 48, pp.153~158 (2018)
  43. Majeed M, "Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome : a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study", Food Nutr Res, 62, pp.1218~ (2018)
  44. Marcial GE, "Lactobacillus johnsonii N6.2 modulates the host immune responses: a double-blind, randomized trial in healthy adults", Front Immunol, 8, pp.655~ (2017)
  45. Pinto-Sanchez MI, "Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity : a pilot study in patients with irritable bowel syndrome", Gastroenterology, 153, pp.448~459 (2017)
  46. Cussotto S, "Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function", Psychopharmacology(Berl), 236, pp.1671~1685 (2019)
  47. Zhang J, "Risk factors for disease severity, unimprovement, and mortality in COVID-19patients in Wuhan, China", Clin Microbiol Infect, 26, pp.767~772 (2020)
  48. Rajkumar RP, "COVID-19 and mental health : a review of the existing literature", Asian J Psychiatr, 52, pp.102066~ (2020)
  49. Wei P, "Neuropeptides in gut-brain axis and their influence on host immunity and stress", Comput Struct Biotechnol J, 18, pp.843~851 (2020)
  50. Alper Evrensel, "The Gut-Brain Axis: The Missing Link in Depression", Clinical Psychopharmacology and Neuroscience, 13(3), pp.239~244 (2015), 대한정신약물학회
  51. Jongho Do, "From Gut to Brain: Alteration in Inflammation Markers in the Brain of Dextran Sodium Sulfate-induced Colitis Model Mice", Clinical Psychopharmacology and Neuroscience, 16(4), pp.422~433 (2018), 대한정신약물학회[DOI]
  52. Nazanin Heidarzadeh-Rad, "Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A Post Hoc Analysis of a Randomized Clinical Trial", Journal of Neurogastroenterology and Motility (JNM), 26(4), pp.486~495 (2020), 대한소화기 기능성질환∙운동학회[DOI]
  53. Wu SI, "Psychobiotic supplementation of PS128TM improves stress, anxiety, and insomnia in highly stressed information technology specialists : a pilot study", Front Nutr, 8, pp.614105~ (2021)
  54. Tian P, "Unraveling the microbial mechanisms underlying the psychobiotic potential of a Bifidobacterium breve strain", Mol Nutr Food Res, 65, pp.e2000704~ (2021)
  55. Sun H, "Altered gene expression signatures by calcitonin gene-related peptide promoted mast cell activity in the colon of stress-induced visceral hyperalgesia mice", Neurogastroenterol Motil, 33, pp.e14073~ (2021)
  56. Barouei J, "Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome", PLoS One, 7, pp.e46051~ (2012)
  57. Vitas JS, "Chemical composition and biological activity of novel types of kombucha beverages with yarrow", J Funct Foods, 44, pp.95~102 (2018)
  58. Magalhães-Guedes KT, "Effect of kefir biomass on nutritional, microbiological, and sensory properties of mangobased popsicles", Int Food Res J, 27, pp.536~545 (2020)
  59. de Souza BL, "Development of arrowroot flour fermented by kefir grains", J Food Sci, 85, pp.3722~3730 (2020)
  60. Davras F, "Immunological effects of Kefir produced from Kefir grains versus starter cultures when fed to mice", Funct Foods Health Dis, 8, pp.412~423 (2018)

관련 논문AI추천

이 간행물의 다른 논문 (19건)